Sexual programing of the rat fetus and neonate studied by selective biochemical testosterone-depriving agents.
D000308:Adrenocortical Hyperfunction / Q000209:etiology; D000818:Animals; D000831:Animals, Newborn; D000917:Antibody Formation; D002369:Castration; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000276:immunology; D006801:Humans; D006908:Hydroxyprogesterones / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000276:immunology; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D012733:Sex Differentiation / Q000187:drug effects*; D012741:Sexual Maturation / Q000187:drug effects*; D013739:Testosterone / Q000096:biosynthesis / Q000172:deficiency / Q000276:immunology
D004791:Enzyme Inhibitors; D006908:Hydroxyprogesterones; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010088:Oxidoreductases; D008525:Medroxyprogesterone; D009640:Norethindrone